US 11986534
Treatment of anthrax with pegylated capsule-degrading enzyme
granted A61KA61K38/45A61K47/60
Quick answer
US patent 11986534 (Treatment of anthrax with pegylated capsule-degrading enzyme) held by The Government of the United States of America, as represented by the Secretary of the Navy expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Government of the United States of America, as represented by the Secretary of the Navy
- Grant date
- Tue May 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/45, A61K47/60